SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Gold/Mining/Energy : Nuvo Research Inc -- Ignore unavailable to you. Want to Upgrade?

To: Tom Johnson who wrote (12956)9/30/2003 9:18:30 AM
From: Ron Nairn  Read Replies (1) | Respond to of 14101
 
Hi Tom,
Do you have a link for this news. I can't find it on the Post, Google, AZ's site or Newswire.

Rondo



To: Tom Johnson who wrote (12956)9/30/2003 9:44:16 AM
From: axial  Respond to of 14101
 
Good to see the expected confirmation, Tom.

Cloutier's opportunity is being interpreted by some as a slam against DMX, when it's nothing of the kind.

So life goes on... and we're one day closer to WF10 news.

Jim



To: Tom Johnson who wrote (12956)10/1/2003 12:28:53 AM
From: Cal Gary  Read Replies (1) | Respond to of 14101
 
Dear Tom,

Thanks for the surprise.

Last fiscal year, AstraZeneca did $17.8 Billion usd revenues. $726mm cash, almost $4 Billion in short term investments and net assets of $11.2 billion. They have several billion dollar drugs. However, their product line does not include any Arthritis products!!

Curious?


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News